skip to Main Content
3T Biosciences
  • About Us
  • Team
  • Technology
  • Publications
  • Investors
  • Pipeline
  • News
  • Careers
  • Contact

News

Media contact: Lissa Quirino, pr@3tbiosciences.com

3T Biosciences Appoints Industry Veteran John Connolly as Interim CEO

December 16, 2020

High Throughput Technology Drives Developments in Personalized Cancer Immuno-therapies

June 9, 2020

Forbes: 3T Biosciences

May 5, 2020

Peter Thiel Among Investors Who Helped 3T Biosciences Close a $12 Million Funding Round

October 7, 2017

Peter Thiel and Sean Parker are financing a secretive cancer-fighting start-up, source says

October 4, 2017

3T Biosciences
681 Gateway Blvd
South San Francisco, CA 94080

© 2021 3T Biosciences, Inc. All Rights Reserved.

  • Privacy Policy
  • Terms of Service
  • Sitemap
  • Site By Razorfrog
Back To Top
We use cookies to ensure the best possible experience for our visitors. Please visit our privacy policy to review our cookies policy. By clicking "I Accept" or continuing to browse, you accept the use of cookies on this site.I Accept